CLINICAL OUTCOMES OF DIABETIC MACULAR EDEMA PATIENTS TREATED WITH FARICIMAB AND AFLIBERCEPT: A SUBCOHORT ANALYSIS OF 20/50 OR WORSE VISUAL ACUITY ACROSS FARICIMAB PHASE 3 CLINICAL TRIALS

被引：0
|
作者：
Zarbin, M. [1 ]
Ding, A. [2 ]
Tabano, D. [2 ]
Ahmed, A. [2 ]
Yang, M. [2 ]
Evolo, V [2 ]
Stoilov, I [2 ]
Amador, M. [2 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
[2] Genentech Inc, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO86
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] Efficacy of Faricimab versus Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase III YOSEMITE and RHINE Trials
    Zarbin, Marco
    Tabano, David
    Ahmed, Ayesha
    Amador, Manuel
    Ding, Allan
    Holekamp, Nancy
    Lu, Xiao-Yu
    Stoilov, Ivaylo
    Yang, Ming
    OPHTHALMOLOGY, 2024, 131 (11) : 1258 - 1270
  • [2] YOSEMITE and RHINE Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale
    Eter, Nicole
    Singh, Rishi P.
    Abreu, Francis
    Asik, Kemal
    Basu, Karen
    Baumal, Caroline
    Chang, Andrew
    Csaky, Karl G.
    Haskova, Zdenka
    Lin, Hugh
    Ruiz, Carlos Quezada
    Ruamviboonsuk, Paisan
    Silverman, David
    Wykoff, Charles C.
    Willis, Jeffrey R.
    OPHTHALMOLOGY SCIENCE, 2022, 2 (01):
  • [3] Short-Term Clinical Outcomes of Patients with Diabetic Macular Edema Following a Therapy Switch to Faricimab
    Wolfrum, Peter
    Boehm, Elsa Wilma
    Lorenz, Katrin
    Stoffelns, Bernhard
    Pfeiffer, Norbert
    Korb, Christina A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [4] Real-world clinical and anatomical outcomes in patients with diabetic macular edema treated with faricimab: The FARETINA-DME study
    Borkar, Durga S.
    Tabano, David
    Ko, Stella
    Leng, Theodore
    Shaia, Jacqueline K.
    Myers, Rachel
    LaPrise, Andrew
    Ali, Ferhina
    Singh, Rishi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [5] Design and rationale of the YOSEMITE and RHINE trials: two phase 3 studies of faricimab in patients with diabetic macular edema
    Eter, Nicole
    Willis, Jeffrey R.
    Ruiz, Carlos Quezada
    Abreu, Francis
    Lin, Hugh
    Silverman, David
    Ives, Jane
    Basu, Karen
    Haskova, Zdenka
    Asik, Kemal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [6] Outcomes of Intravitreal Bevacizumab for Diabetic Macular Edema in Patients with Visual Acuity Worse than 20/200
    Mac Cord, Flavio
    Estacia, Carolina Tagliari
    Gameiro Filho, Aluisio Rosa
    dos Santos Motta, Mario Martins
    Alburquerque Junior, Aderbal
    Motta, Augusto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [7] Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema
    Kalavar, Meghana
    Sridhar, Jayanth
    CURRENT OPINION IN OPHTHALMOLOGY, 2025, 36 (03) : 189 - 198
  • [8] Primary Results from Two Phase 3 Trials of Faricimab for Diabetic Macular Edema (DME): YOSEMITE and RHINE
    Hu, Allen
    Willis, Jeffrey R.
    Haskova, Zdenka
    Silverman, David
    Ives, Jane
    Basu, Karen
    Lin, Hugh
    DIABETES, 2021, 70
  • [9] FARETINA-DME- Early Treatment Patterns and Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: an IRIS Registry™Analysis
    Tabano, David
    Borkar, Durga S.
    Garmo, Vincent
    Shaia, Jacqueline K.
    Kuo, Blanche
    Myers, Rachel
    LaPrise, Andrew
    Leng, Theodore
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
12345